Literature DB >> 21515609

Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma.

Ik Jae Lee1, Jinsil Seong, Woong Sub Koom, Yong Bae Kim, Byeong Chul Jeon, Joo Ho Kim, Kwang Hyub Han.   

Abstract

OBJECTIVE: Various techniques are available for radiotherapy of hepatocellular carcinoma, including three-dimensional conformal radiotherapy, linac-based intensity-modulated radiotherapy and helical tomotherapy. The purpose of this study was to determine the optimal radiotherapy technique for hepatocellular carcinoma.
METHODS: Between 2006 and 2007, 12 patients underwent helical tomotherapy for locally advanced hepatocellular carcinoma. Helical tomotherapy computerized radiotherapy planning was compared with the best computerized radiotherapy planning for three-dimensional conformal radiotherapy and linac-based intensity-modulated radiotherapy for the delivery of 60 Gy in 30 fractions. Tumor coverage was assessed by conformity index, radical dose homogeneity index and moderated dose homogeneity index. Computerized radiotherapy planning was also compared according to the tumor location.
RESULTS: Tumor coverage was shown to be significantly superior with helical tomotherapy as assessed by conformity index and moderated dose homogeneity index (P= 0.002 and 0.03, respectively). Helical tomotherapy showed significantly lower irradiated liver volume at 40, 50 and 60 Gy (V40, V50 and V60, P= 0.04, 0.03 and 0.01, respectively). On the contrary, the dose-volume of three-dimensional conformal radiotherapy at V20 was significantly smaller than those of linac-based intensity-modulated radiotherapy and helical tomotherapy in the remaining liver (P= 0.03). Linac-based intensity-modulated radiotherapy showed better sparing of the stomach compared with helical tomotherapy in the case of separated lesions in both lobes (12.3 vs. 24.6 Gy). Helical tomotherapy showed the high dose-volume exposure to the left kidney due to helical delivery in the right lobe lesion.
CONCLUSIONS: Helical tomotherapy achieved the best tumor coverage of the remaining normal liver. However, helical tomotherapy showed much exposure to the remaining liver at the lower dose region and left kidney.

Entities:  

Mesh:

Year:  2011        PMID: 21515609     DOI: 10.1093/jjco/hyr053

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  11 in total

Review 1.  Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma.

Authors:  Cha Jihye; Seong Jinsil
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

2.  Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma.

Authors:  Hong In Yoon; Ik Jae Lee; Kwang-Hyub Han; Jinsil Seong
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-09       Impact factor: 4.553

Review 3.  Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma.

Authors:  Hong In Yoon; Jinsil Seong
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

4.  Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma.

Authors:  Mian Xi; Li Zhang; Qiao-Qiao Li; Lei Zhao; Rui Zhang; Meng-Zhong Liu
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

5.  Exploration of Superior Modality: Safety and Efficacy of Hypofractioned Image-Guided Intensity Modulated Radiation Therapy in Patients with Unresectable but Confined Intrahepatic Hepatocellular Carcinoma.

Authors:  Tao Jiang; Zhao-Chong Zeng; Ping Yang; Yong Hu
Journal:  Can J Gastroenterol Hepatol       Date:  2017-10-01

Review 6.  Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results.

Authors:  Sun Hyun Bae; Won Il Jang; Hee Chul Park
Journal:  Oncotarget       Date:  2017-07-13

7.  Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Ji-Yoon Kim; Eun-Jung Yoo; Jeong-Won Jang; Jung-Hyun Kwon; Ki-Jun Kim; Chul-Seung Kay
Journal:  Radiat Oncol       Date:  2013-01-16       Impact factor: 3.481

8.  The optimal selection of radiotherapy treatment for hepatocellular carcinoma.

Authors:  Ik Jae Lee; Jinsil Seong
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

9.  Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: dosimetric comparison and risk assessment of solid secondary cancer.

Authors:  Sun Hyun Bae; Dong Wook Kim; Mi-Sook Kim; Myung-Hee Shin; Hee Chul Park; Do Hoon Lim
Journal:  Radiat Oncol J       Date:  2017-02-13

10.  Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage.

Authors:  Sun Hyun Bae; Kwang Hwan Cho; Young Seok Kim; Sang Gyune Kim; Jeong-Ju Yoo; Jae Myung Lee; Min Hee Lee; Sanghyeok Lim; Jae Hong Jung; Sung Hee Lim
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.